Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis Article (Faculty180)

cited authors

  • Luni, Faraz Kha K; Riaz, Haris; Khan, Abdur Rahma R; Riaz, Talha; Husnain, Muhammad; Riaz, Irbaz Bi B; Khan, Muhammad Shahze S; Taleb, Mohammed; Kanjwal, Yusuf; Cooper, Christopher J; Khuder, Sadik A

description

  • Postoperative state is characterized by increased thrombotic risk by virtue of platelet activation. Whether aspirin ameliorates this risk in patients with established coronary artery disease undergoing cardiac or noncardiac surgery is unknown. We conducted a systematic review and meta-analysis to compare the risk of major adverse cardiac events (MACE) and the risk of bleeding in patients with early (3-5 or more days before surgery) vs. late discontinuation(<3-5 days)/no discontinuation of aspirin.

authors

publication date

  • 2017

published in

start page

  • 1168

end page

  • 1175

volume

  • 89